Prediction of activity in eyes with macular neovascularization due to age-related macular degeneration using deep learning
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Prediction of activity in eyes with macular neovascularization due to age-related macular degeneration using deep learning ; day:26 ; month:10 ; year:2023 ; pages:1-3
Eye ; (26.10.2023), 1-3
- Creator
-
Corradetti, Giulia
Rakocz, Nadav
Chiang, Jeffrey N.
Avram, Oren
Alagorie, Ahmed Roshdy
Nittala, Muneeswar Gupta
Karamat, Ayesha
Boyer, David S.
Sarraf, David
Halperin, Eran
Sadda, SriniVas
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41433-023-02805-4
- URN
-
urn:nbn:de:101:1-2024011511411075362188
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Corradetti, Giulia
- Rakocz, Nadav
- Chiang, Jeffrey N.
- Avram, Oren
- Alagorie, Ahmed Roshdy
- Nittala, Muneeswar Gupta
- Karamat, Ayesha
- Boyer, David S.
- Sarraf, David
- Halperin, Eran
- Sadda, SriniVas
- SpringerLink (Online service)
Other Objects (12)
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Quantitative assessment of choriocapillaris flow deficits and type 1 macular neovascularization growth in age-related macular degeneration
Type 1 neovascularization may confer resistance to geographic atrophy amongst eyes treated for neovascular age-related macular degeneration
Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Quantitative assessment of choriocapillaris flow deficits and type 1 macular neovascularization growth in age-related macular degeneration
Type 1 neovascularization may confer resistance to geographic atrophy amongst eyes treated for neovascular age-related macular degeneration
Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment
Mast cells promote choroidal neovascularization in a model of age-related macular degeneration
Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Current Perspectives on Type 3 Macular Neovascularization due to Age-Related Macular Degeneration
Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
Brolucizumab for recalcitrant macular neovascularization in age-related macular degeneration with pigment epithelial detachment
Correction to: Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
Age-related macular degeneration
Growth of nonexudative macular neovascularization in age-related macular degeneration: an indicator of biological lesion activity
Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
Quantitative assessment of choriocapillaris flow deficits and type 1 macular neovascularization growth in age-related macular degeneration
Type 1 neovascularization may confer resistance to geographic atrophy amongst eyes treated for neovascular age-related macular degeneration
Pachychoroid neovasculopathy versus macular neovascularization in age-related macular degeneration with and without shallow irregular pigment epithelial detachment